D. E. Shaw & Co., Inc. Esperion Therapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $198,450 - $373,975	-17,500 Reduced 58.33%	12,500 $151,000
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $1.77 Million - $2.99 Million	-50,000 Reduced 62.5%	30,000 $1.79 Million
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $1.72 Million - $2.38 Million	50,000 Added 166.67%	80,000 $2.93 Million
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $685,710 - $894,843	17,100 Added 132.56%	30,000 $1.4 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $466,980 - $985,560	12,900 New	12,900 $506,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $146M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.